These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3018705)

  • 1. Structural requirements for gastric inhibitory polypeptide (GIP) receptor binding and stimulation of insulin release.
    Maletti M; Carlquist M; Portha B; Kergoat M; Mutt V; Rosselin G
    Peptides; 1986; 7 Suppl 1():75-8. PubMed ID: 3018705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding specificity and signal transduction of receptors for glucagon-like peptide-1(7-36)amide and gastric inhibitory polypeptide on RINm5F insulinoma cells.
    Gallwitz B; Witt M; Fölsch UR; Creutzfeldt W; Schmidt WE
    J Mol Endocrinol; 1993 Jun; 10(3):259-68. PubMed ID: 8396943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a bioactive domain in the amino-terminus of glucose-dependent insulinotropic polypeptide (GIP).
    Hinke SA; Manhart S; Pamir N; Demuth H; W Gelling R; Pederson RA; McIntosh CH
    Biochim Biophys Acta; 2001 May; 1547(1):143-55. PubMed ID: 11343800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Demonstration of specific receptors for gastric inhibitory peptide (GIP)].
    Maletti M; Amiranoff B; Laburthe M; Rosselin G
    C R Seances Acad Sci III; 1983; 297(12):563-5. PubMed ID: 6324966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional GIP receptors in a hamster pancreatic beta cell line, In 111: specific binding and biological effects.
    Amiranoff B; Vauclin-Jacques N; Laburthe M
    Biochem Biophys Res Commun; 1984 Sep; 123(2):671-6. PubMed ID: 6091638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP). Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the rat.
    Tseng CC; Kieffer TJ; Jarboe LA; Usdin TB; Wolfe MM
    J Clin Invest; 1996 Dec; 98(11):2440-5. PubMed ID: 8958204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic AMP production and insulin releasing activity of synthetic fragment peptides of glucose-dependent insulinotropic polypeptide.
    Gault VA; Harriott P; Flatt PR; O'Harte FP
    Biosci Rep; 2002; 22(5-6):523-8. PubMed ID: 12635849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships of glucose-dependent insulinotropic polypeptide (GIP).
    Hinke SA; Gelling R; Manhart S; Lynn F; Pederson RA; Kühn-Wache K; Rosche F; Demuth HU; Coy D; McIntosh CH
    Biol Chem; 2003 Mar; 384(3):403-7. PubMed ID: 12715891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GIP(3-30)NH
    Sparre-Ulrich AH; Gabe MN; Gasbjerg LS; Christiansen CB; Svendsen B; Hartmann B; Holst JJ; Rosenkilde MM
    Biochem Pharmacol; 2017 May; 131():78-88. PubMed ID: 28237651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of glucose-induced insulin secretion in the perfused rat pancreas by porcine GIP (gastric inhibitory polypeptide), bovine GIP, and bovine GIP(1-39).
    Sandberg E; Ahrén B; Tendler D; Carlquist M; Efendić S
    Acta Physiol Scand; 1986 Jul; 127(3):323-6. PubMed ID: 3529825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning, functional expression, and signal transduction of the GIP-receptor cloned from a human insulinoma.
    Volz A; Göke R; Lankat-Buttgereit B; Fehmann HC; Bode HP; Göke B
    FEBS Lett; 1995 Oct; 373(1):23-9. PubMed ID: 7589426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose-dependent insulinotropic polypeptide stimulated insulin release from a tumor-derived beta-cell line (beta TC3).
    Kieffer TJ; Verchere CB; Fell CD; Huang Z; Brown JC; Pedersen RA
    Can J Physiol Pharmacol; 1993 Dec; 71(12):917-22. PubMed ID: 7910109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GIP(6-30amide) contains the high affinity binding region of GIP and is a potent inhibitor of GIP1-42 action in vitro.
    Gelling RW; Coy DH; Pederson RA; Wheeler MB; Hinke S; Kwan T; McIntosh CH
    Regul Pept; 1997 Apr; 69(3):151-4. PubMed ID: 9226399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational, receptor interaction and alanine scan studies of glucose-dependent insulinotropic polypeptide.
    Venneti KC; Malthouse JP; O'Harte FP; Hewage CM
    Biochim Biophys Acta; 2011 Jul; 1814(7):882-8. PubMed ID: 21539943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-I-(7-36) on insulin secretion.
    Jia X; Brown JC; Ma P; Pederson RA; McIntosh CH
    Am J Physiol; 1995 Apr; 268(4 Pt 1):E645-51. PubMed ID: 7733263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the novel (Pro3)GIP antagonist and exendin(9-39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological incretin.
    Gault VA; O'Harte FP; Harriott P; Mooney MH; Green BD; Flatt PR
    Diabetologia; 2003 Feb; 46(2):222-30. PubMed ID: 12627321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved stability, insulin-releasing activity and antidiabetic potential of two novel N-terminal analogues of gastric inhibitory polypeptide: N-acetyl-GIP and pGlu-GIP.
    O'Harte FP; Gault VA; Parker JC; Harriott P; Mooney MH; Bailey CJ; Flatt PR
    Diabetologia; 2002 Sep; 45(9):1281-91. PubMed ID: 12242461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholecystokinin-33 potentiates and vasoactive intestinal polypeptide inhibits gastric inhibitory polypeptide--induced insulin secretion in the perfused rat pancreas.
    Sandberg E; Ahrén B; Tendler D; Efendic S
    Acta Endocrinol (Copenh); 1988 Apr; 117(4):545-51. PubMed ID: 3291528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose-dependent insulinotropic polypeptide is expressed in pancreatic islet alpha-cells and promotes insulin secretion.
    Fujita Y; Wideman RD; Asadi A; Yang GK; Baker R; Webber T; Zhang T; Wang R; Ao Z; Warnock GL; Kwok YN; Kieffer TJ
    Gastroenterology; 2010 May; 138(5):1966-75. PubMed ID: 20138041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GIP-(3-42) does not antagonize insulinotropic effects of GIP at physiological concentrations.
    Deacon CF; Plamboeck A; Rosenkilde MM; de Heer J; Holst JJ
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E468-75. PubMed ID: 16608883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.